反应条件
1: 5-(4,4,5,5-tetramethyl-1,3 ,2-dioxaborolan-2-yl)- 1 H-pyrrolo[2,3-b]pyridine With sodium hydride in N,N-dimethyl-formamide T=0°C; 0.5 h; 2: methyl iodide in N,N-dimethyl-formamide T=20°C; 1 h;
参考文献
NOVARTIS AG; FURET, Pascal; IMBACH, Patricia; MAH, Robert; STAUFFER, Frederic
Patent: WO2010/139747 A1, 2010 ;
Location in patent: Page/Page column 106 ;
WO 2010/139747 A1
